In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...
Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy ...
October 2025 proved to be a significant month for the oncology landscape, marked by a wave of key regulatory decisions from the US FDA. This period saw important full and accelerated drug approvals ...
More than 580,000 bottles of a popular blood pressure medication distributed nationwide have been recalled, according to the U.S. Food and Drug Administration. The recall involves bottles of Prazosin ...
This article originally published at FDA expands recall on cinnamon products due to lead hazard. Symptoms of the condition vary from person to person, but there are a few feelings and habits to note.
U.S. President Donald Trump's embrace of an old generic drug called leucovorin for use against a rare disorder that causes ...
Over half a million bottles of prazosin hydrochloride have been recalled for having high levels of potentially cancer-causing ...
Teva Pharmaceuticals USA and drug distributor Amerisource Health Services has recalled more than half a million bottles of a ...
The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a ...
Blood pressure medication was recalled by the FDA. The prescription drug didn’t meet the agency’s standards for a lack of ...
Numerous recalls have been initiated this year because of the potential for damaged products, foodborne illness and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results